Histopathology of Barrett's esophagus after ablation and endoscopic mucosal resection therapy

被引:45
|
作者
Odze, R. D. [1 ]
Lauwers, G. Y. [2 ]
机构
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
关键词
D O I
10.1055/s-0028-1103416
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
This review focuses on the histopathological evaluation of endoscopic mucosal resection (EMR) specimens in Barrett's esophagus, and on the histopathological, biological, and molecular properties of postablation Barrett's esophagus. EMR may be used for both diagnostic and therapeutic purposes. Diagnostic accuracy regarding the grade and stage of neoplasms is improved with the use of EMR, but the value of this technique for treatment is more controversial because of the high prevalence rate of positive margins and the rate of metachronous lesions found elsewhere in the esophagus during follow-up. Ablation techniques, such as argon plasma coagulation, photodynamic therapy, and radiofrequency ablation, are used increasingly for the treatment of Barrett's esophagus and related neoplasms, often in combination with EMR. A common problem after use of these techniques is the development of islands of neosquamous epithelium (NSE) which can overlie buried Barrett's (and/or dysplasia) epithelium. This is, therefore, concealed to the endoscopist's view and may be allowed to progress to cancer without detection. NSE is histologically similar to normal esophageal squamous epithelium and does not possess the molecular aberrations characteristic of Barrett's esophagus. In contrast, residual nonburied Barrett's esophagus shows persistent pathologic and molecular abnormalities and may progress to cancer upon long term followup. The biological potential and rate of progression of nonburied residual Barrett's esophagus following ablation is unclear, but some preliminary studies suggest that the risk may decrease. Buried nondysplastic Barrett's esophagus appears to show decreased biological potential and this may be related to protection from the contents of the lumen by the barrier function of the overlying NSE. On the other hand, anecdotal reports have suggested that buried dysplasia may progress to cancer in some instances. © Georg Thieme Verlag KG Stuttgart.
引用
收藏
页码:1008 / 1015
页数:8
相关论文
共 50 条
  • [31] Complications of Therapy in Patients with Barrett's Esophagus - Comparison of Radiofrequency Ablation (RFA) alone with and without prior Endoscopic Mucosal Resection (EMR)
    Okoro, Ngozi
    Tomizawa, Yutaka
    Prasad, Ganapathy
    Buttar, Navtej
    Song, Louis-Michel Wong Kee
    Lutzke, Lori
    Dunagan, Kelly
    Borkenhagen, Lynn
    Wang, Kenneth
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S539 - S539
  • [32] Hemoclip Retention Following Endoscopic Mucosal Resection (EMR) in Barrett's Esophagus
    Vikneswaran, Namasivayam
    Dierkhising, Ross A.
    Okoro, Ngozi I.
    Lutzke, Lori S.
    Tomizawa, Yutaka
    Prasad, Ganapathay A.
    Dunagan, Kelly T.
    Borkenhagen, Lynn S.
    Buttar, Navtej
    Song, Louis-Michel Wong Kee
    Zinsmeister, Alan R.
    Wang, Kenneth K.
    GASTROINTESTINAL ENDOSCOPY, 2010, 71 (05) : AB182 - AB182
  • [33] Endoscopic mucosal resection (EMR) as treatment for Barrett's esophagus with dysplasia or cancer
    Ross, A
    Kinney, T
    Chi, K
    Shami, V
    Waxman, I
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S312 - S312
  • [34] Squamous reepithelialization after circumferential endoscopic mucosal resection of superficial carcinoma arising in Barrett's esophagus
    Satodate, H
    Inoue, H
    Fukami, N
    Shiokawa, A
    Kudo, SE
    ENDOSCOPY, 2004, 36 (10) : 909 - 912
  • [35] Factors associated with esophageal stricture formation after endoscopic mucosal resection for neoplastic Barrett's esophagus
    Lewis, Jason J.
    Rubenstein, Joel H.
    Singal, Amit G.
    Elmunzer, B. Joseph
    Kwon, Richard S.
    Piraka, Cyrus R.
    GASTROINTESTINAL ENDOSCOPY, 2011, 74 (04) : 753 - 760
  • [36] Clonal Diversity of Barrett's Esophagus With High Grade Dysplasia Decreases After Endoscopic Mucosal Resection
    Westra, Wytske
    de Wit, Gerard M.
    Iyer, Prasad G.
    Brankley, Shannon
    Halling, Kevin C.
    Buttar, Navtej
    Song, Louis M. Wong Kee
    Lutzke, Lori S.
    Dunagan, Kelly T.
    Goddard, Teresa
    Wang, Kenneth K.
    Krishnadath, Kausilia K.
    GASTROENTEROLOGY, 2013, 144 (05) : S186 - S186
  • [37] Combining endoscopic submucosal dissection and endoscopic mucosal resection to treat neoplasia in Barrett's esophagus
    Holmes, Ian
    Hing, Tressia
    Friedland, Shai
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2016, 30 (12): : 5330 - 5337
  • [38] Combining endoscopic submucosal dissection and endoscopic mucosal resection to treat neoplasia in Barrett’s esophagus
    Ian Holmes
    Tressia Hing
    Shai Friedland
    Surgical Endoscopy, 2016, 30 : 5330 - 5337
  • [39] Combining Endoscopic Submucosal Dissection and Endoscopic Mucosal Resection to Treat Neoplasia in Barrett's Esophagus
    Holmes, Ian
    Hing, Tressia
    Friedland, Shai
    GASTROINTESTINAL ENDOSCOPY, 2016, 83 (05) : AB558 - AB558
  • [40] Endoscopic Mucosal Resection vs Endoscopic Submucosal Dissection For Barrett's Esophagus and Colorectal Neoplasia
    Yang, Dennis
    Othman, Mohamed
    Draganov, Peter V.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (06) : 1019 - 1028